Sue Marshall blogs about diabetes for Desang
Meditation Medication – Diabetes Health
Leave a Comment
Meditation Medication by Russell Phillips, Phd
“Living with a chronic condition like diabetes can be a challenging and stressful experience. Unfortunately, all the worry about blood glucose and the constant effort to balance insulin against food intake and exercise can itself raise blood glucose levels. But stress management can help control the stress hormones that affect blood glucose levels. Yoga practice, for example, can have a calming effect and play a major role in stress management.”
Pump Location Can Impact Insulin Delivery | Diabetes News Hound
Leave a Comment
Changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact the expected insulin delivery rates, according to researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara.
The height of the pump and tubing can often change during simple, everyday activities, such as dressing, sleeping or changing clothes. When the pump was moved higher or lower relative to its tubing or infusion site, the accuracy of insulin delivery rates were impacted.
“The unintended fluctuation in insulin delivery, which may arise from pump movement during normal daily use, can increase blood glucose variability, a risk factor for the progression of complications of diabetes,” said lead investigator Howard Zisser, MD, Director of Clinical Research and Diabetes Technology at the Sansum Diabetes Research Institute in Santa Barbara, CA. “The effect of hydrostatic pressure was most significant at low basal rates and therefore these findings may be particularly important for pediatric diabetes patients, who often use insulin pumps at low basal rates.”
In contrast, the OmniPod, which has no external tubing, was the least affected by pumping orientation and direction.
The study was published in the January issue of Journal of Diabetes Science and Technology.
via Pump Location Can Impact Insulin Delivery | Diabetes News Hound.
Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Ashleigh Lin. 2010; Pediatric Diabetes – Wiley InterScience
Leave a Comment
A stuay – Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset (Lin A, Northam EA, Rankins D, Werther GA, Cameron FJ.) – has documented poorer neuropsychological performance and its association with illness risk factors in youth with type 1 diabetes. Findings suggest that early disease onset and hypoglycemia impact on the developing central nervous system, with hyperglycemia playing a lesser role.
UK Study Says Bisphenol A (BPA) Is Connected to Increased Risks for Diabetes and Coronary Heart Disease – Diabetes Health
Leave a Comment
Patrick Totty writing in Diabetes Health looks at a study by researchers at the universities of Exeter and Plymouth in the United Kingdom which says that Bisphenol A-BPA-a chemical commonly used in plastic packaging and products, is associated with an increased risk of diabetes and coronary heart disease.
Very interesting. Can diabetes be environmentally induced?
Victoza approved for US market
Leave a Comment
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults.1
Victoza is the brand name approved in the US and Europe for liraglutide, the first once-daily human Glucagon-like peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes. In the US, Victoza® is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. This provides for Victoza® to be used in monotherapy, (although not as first line therapy) and in combination with commonly prescribed oral medications for diabetes.
In Europe, EU Commission granted marketing authorisation for liraglutide on 30 June 2009, for all 27 European Union member states.2 It has been on the market in the UK since 7 July 2009. According to the EU authorisation, liraglutide is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with:
- Metformin or a sulphonylurea in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea, and
- Metformin and a sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycaemic control despite dual therapy.
“The US approval of liraglutide represents an important milestone for Novo Nordisk that follows the recent approval in Japan and the ongoing successful launch in Europe”, says Lars Rebien Sørensen, president and CEO. “We are convinced that liraglutide will prove to be a valuable treatment option for people with type 2 diabetes in the US.”
Novo Nordisk expects to introduce Victoza in the US market within weeks.
via Health4Media.com.
Diabetes Goes Undiagnosed Due to Flaws in Screening – Diabetes Health
Leave a Comment
MADISON, Wis. – Using one of the two major national diabetes screening guidelines misses about one-third of those with diabetes, consequently putting them at risk for serious health complications, according to surprising research findings at the University of Wisconsin School of Medicine and Public Health.
via Diabetes Goes Undiagnosed Due to Flaws in Screening – Diabetes Health.
Insulin Pump Cases .:. Story – Angel Bear
Leave a Comment
Another super little website founded by someone affected by diabetes and inspired to bring carrycase solutions to the wider diabetes community. “Angel Bear Pump Stuff Inc was formed in 2004, in honor of my four-year-old diabetic granddaughter, Ashley Kate, and her beloved white stuffed polar bear.”
Skier with Type 1 Diabetes to Compete for U.S. Olympic Team | Diabetes News Hound
Leave a Comment
Cross-country skier Kris Freeman, who has Type 1 diabetes, has won a spot on the US Ski Team and will compete in the 2010 Olympic Games this February in Vancouver. Freeman, who is a three-time Olympian, competes in all three cross country events.
via Skier with Type 1 Diabetes to Compete for U.S. Olympic Team | Diabetes News Hound.
New Blood Glucose Monitor Would Be a Breath of Fresh Air | Diabetes News Hound
Leave a Comment
A recent article from the magazine Diabetes Forecast says that scientists are trying to develop a way to measure blood sugar levels by analyzing your breath.
University of California-Irvine scientist Pietro Galassetti, MD, PHD, is working with a grant from the American Diabetes Association to try and make the breath test a reality. Before current glucose monitors were developed, smelling the breath of diabetics was one way people could informally test for blood sugar problems.
Now, Galassetti is using technology originally designed to identify chemicals in the atmosphere. He is also working to develop an algorithm to make sense of the data collected from such breath tests. Such an algorithm is needed to be able to provide blood sugar readings from the data.
However, even if everything goes as planned, breath-test monitors are still a long way off. If successful, Galassetti hopes that the private sector can refine the technology and bring it to market within the next 20 years.
via New Blood Glucose Monitor Would Be a Breath of Fresh Air | Diabetes News Hound.
Record numbers take part in the National Diabetes Audit
Leave a Comment
Participation figures for the sixth National Diabetes Audit (NDA) have been the highest since the audit began in 2003 – ensuring the NDA remains the largest clinical audit in the world. The 2008/2009 NDA will now provide information and analysis on more than 1.7 million people with diabetes in England and Wales. The participation numbers from all areas is testament to increasing recognition of the value the NDA provides. Primary care participation stands at over 6000 practices in England and Wales.
Desang Diabetes Directory
Sue Marshall picture
